Levetiracetam in patients with cortical
β
Pasquale Striano; Fiore Manganelli; Patrizia Boccella; Anna Perretti; Salvatore
π
Article
π
2005
π
John Wiley and Sons
π
English
β 200 KB
## Abstract Levetiracetam is a new antiepileptic agent that exerts antimyoclonic effects. We conducted an openβlabel trial to evaluate the effect of levetiracetam in chronic cortical myoclonus of diverse etiologies and to determine whether levetiracetam affects electrophysiological findings. Sixtee